Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now later-stage tilt small index

Drive: later-stage trial registry

2 of 5 indexed Drive trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 2 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Drive: 5 US clinical trials tracked, 2 recruiting.

Drive is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Ginger Yang, running 3 of these trials.

Enrollment posture brief

Registry condition drive

OPEN 2 | RECR 40% | LATE 2 | EARLY 0 | RANK #3391 | SPON 3

Nearest open-share peer: Achondroplasia (40% recruiting · 10 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Drive (this)40%
Open-enrollment share among volume-matched conditions near Drive

Drive lists 2 open slots (40% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Drive on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Drive is recruiting below its size-band peers.

    2 of 5 indexed trials (40%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Drive research.

    Ginger Yang accounts for 3 of 5 trials (60%). 3 distinct sponsors appear on at least one study for this condition label.

  3. Typical Drive enrolment sits around 180 participants.

    Median target enrolment is 180 among the 5 trials that report a genuine target (sentinel values excluded). 1 of those (20%) plan for fewer than 100 participants.

  4. Drive splits between interventional and observational designs.

    3 interventional and 2 observational studies make up this index (60% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 32

Phase Distribution

PhaseTrial count
Phase 3 2

Top Sponsors

Named interventions

Most-linked intervention names on Drive records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Driving Feedback Technology. Behavioral
1 trials
Steering Teens Safe (STS) Behavioral
1 trials
Parent Communication Behavioral
1 trials
In-vehicle device Combination
1 trials
Peer-Delivered Parent Communication Training Behavioral
1 trials
Expert-Delivered Parent Communication Training Behavioral
1 trials
In-vehicle Device Combination
1 trials
[11C]-Pittsburgh Compound B ([11C]PiB) Drug
1 trials

US sites by state

Facility locations filed on Drive trials. A trial with sites in several states counts in each.

Ohio 3 trials
Texas 1 trials
Missouri 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Drive page

5 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Drive condition card totals 5 registered trials; most-linked intervention Driving Feedback Technology.; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.